Phia Group

Back to School: 2020 Renewals

On August 21, 2019
As players in the self-funded industry have found out the hard way, keeping business often isn’t easy. Fiduciary obligations and other difficult situations can arise when we all least expect them, and when we are worst-equipped to deal with them (such as in the height of renewal season). By popular demand, this month’s webinar will focus on when fiduciary duties can arise, who needs to be careful, and how those duties might affect your 2020 renewals.

Faces of Phia: Episode 15 - The Fine Fan Club!

On August 16, 2019
In this episode, learn more about the life and background of Andrew Fine, Phia’s Lead Intake Specialist. Listen in as Andrew discusses his family, the fan club behind him, compliance being the number one priority for plans, and the bittersweet nature of the Celtics. Listen in closely, as the former sports analyst might give you some insider tips!

Controversy Surrounds the Most Expensive Drug in the World

On August 13, 2019
In May of this year, the Federal Drug Administration (FDA) approved the most expensive drug in the world, Zolgensma. The drug was developed by Swiss drug maker, Novartis, and costs $2.1 million for the one-time single dose. The drug maker will spread the burden of the high cost by allocating payments for the drug over a 5- year plan at $425,000 a year.

Don’t Confuse Appeals with Balance-Billing!

On August 6, 2019
https://www.phiagroup.com/Media/Posts/PostId/878/controversy-surrounds-the-most-expensive-drug-in-the-world

Faces of Phia: Episode 14 – The Magical Kingdom!

On August 1, 2019
In this episode, prepare to be enchanted by Mattie Sesin, our Director of Recovery Services. Like a toad kissed by a princess, her career has transformed – and we invite you to join the journey. Marvel at the tales of family, festivities, and food. Miss this one, and you’ll likely turn into a pumpkin.